Stability of rare TP53 co-mutations in AML patients.

被引：0
|
作者：
Bloom, Kenneth Joel
Idica, Adam
Smart, Dave
Allen, Wendy
Scanlon, Enya
Clark, Jordan
机构：
[1] Clarient Diagnost Serv Inc, Aliso Viejo, CA USA
[2] DIACEUTICS, Carlsbad, CA USA
[3] Diaceutics, Belfast, Antrim, North Ireland
[4] Queens Univ Belfast, Belfast, Antrim, North Ireland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7528
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The role of PTEN and TP53 co-mutations in immunotherapy of lung cancer.
    Ma, Xiaolong
    Zhang, Ding
    Chen, Shiqing
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [2] Targeting the Chemoradiation Resistance of Lung Cancers with KRAS/TP53 Co-Mutations
    Willers, H.
    Gurtner, K.
    Benes, C.
    Baumann, M.
    Krause, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (11) : S1138 - S1139
  • [3] Patterns of mutations in TP53 mutated AML
    Welch, John S.
    [J]. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2018, 31 (04) : 379 - 383
  • [4] TP53/KRAS Co-Mutations Create Divergent Prognosis Signatures in Intrahepatic Cholangiocarcinoma
    Guo, Chunguang
    Liu, Zaoqu
    Yu, Yin
    Chen, Yunfang
    Liu, Hui
    Guo, Yaming
    Peng, Zhenyu
    Cai, Gaopo
    Hua, Zhaohui
    Han, Xinwei
    Li, Zhen
    [J]. FRONTIERS IN GENETICS, 2022, 13
  • [5] Immunosignatures associated with TP53 status and co-mutations classify prognostically head and neck cancer patients
    Sacconi, Andrea
    Muti, Paola
    Pulito, Claudio
    Urbani, Giulia
    Allegretti, Matteo
    Pellini, Raul
    Mehterov, Nikolay
    Ben-David, Uri
    Strano, Sabrina
    Bossi, Paolo
    Blandino, Giovanni
    [J]. MOLECULAR CANCER, 2023, 22 (01)
  • [6] Immunosignatures associated with TP53 status and co-mutations classify prognostically head and neck cancer patients
    Andrea Sacconi
    Paola Muti
    Claudio Pulito
    Giulia Urbani
    Matteo Allegretti
    Raul Pellini
    Nikolay Mehterov
    Uri Ben-David
    Sabrina Strano
    Paolo Bossi
    Giovanni Blandino
    [J]. Molecular Cancer, 22
  • [7] A Pan-Cancer Assessment of RB1/TP53 Co-Mutations
    Cai, Ling
    DeBerardinis, Ralph J.
    Xiao, Guanghua
    Minna, John D.
    Xie, Yang
    [J]. CANCERS, 2022, 14 (17)
  • [8] Reply to: "Survival Analysis of TP53 Co-Mutations Should be Interpreted More Cautiously"
    Saleh, Mohamed Mahde
    Scheffler, Matthias
    Merkelbach-Bruse, Sabine
    Wolf, Jurgen
    Buettner, Reinhard
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (06) : E57 - E59
  • [9] Relations between mutant KRAS and TP53 subtypes and other co-mutations in pancreatic cancer
    Abraham, Soniya
    Zhang, Janie Yue
    Walther, Zenta
    Parekh, Jay
    Lacy, Jill
    Cecchini, Michael
    Hu, Yiduo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [10] Somatic Mutations in TP53 Identified in T-Cells of Patients with TP53-mutated AML
    Issa, Ghayas C.
    Bidikian, Aram
    Ayoub, Edward
    Wang, Feng
    Mohanty, Vakul
    Leighton, Jake
    Wu, Xiaogang
    Patsilevas, Tallie
    Alaniz, Zoe
    Zarka, Jabra
    Kanagal-Shamanna, Rashmi
    Daver, Naval
    Futreal, Andy
    Konopleva, Marina
    Navin, Nicholas
    Zhang, Jianhua
    Chen, Ken
    Andreeff, Michael
    [J]. BLOOD, 2022, 140 : 6267 - 6269
12345